Structural basis for constitutive activation of oncogenic gp130 mutants found in human inflammatory hepatocellular adenomas

Inflammatory hepatocellular adenomas (IHCAs) are benign liver tumors primarily driven by somatic mutations in the gp130 receptor, resulting in its constitutive activation. To uncover the structural mechanisms underlying this activation, we employ cryo-electron microscopy and mutagenesis to study five representative IHCAs-associated gp130 mutants and two engineered mutants with ligand-independent activity. Most mutants form “X”-shaped dimers through a 3D domain-swapping mechanism, characterized by large separations between juxtamembrane domains and reliant on D1 domain-mediated “tip-to-tip” interactions for dimer clustering and activation. A rare mutant displays a distinct “Y”-shaped dimer conformation, with closely aligned juxtamembrane domains enabling direct activation independent of dimer clustering. These findings highlight the diversity of gp130 mutant activation mechanisms and provide a foundation for developing therapeutic strategies targeting aberrant gp130 signaling in IHCAs.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-11-21
DOI
https://doi.org/10.1038/s41467-026-79742-9
Primary Topic
Cytokine Signaling Pathways and Interactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Structural basis for constitutive activation of oncogenic gp130 mutants found in human inflammatory hepatocellular adenomas

Matthew C. Franklin, Jennifer L. Jones, William C. Olson, Raymond Leidich et al.
Nature Communications
Cytokine Signaling Pathways and Interactions
article

Structural basis for constitutive activation of oncogenic gp130 mutants found in human inflammatory hepatocellular adenomas

Matthew C. Franklin, Jennifer L. Jones, William C. Olson, Raymond Leidich, Trudy F. Ramlall, Mark W. Sleeman, Annan SI Cook, Luke L. McGoldrick, Jing Cao, Yi Zhou, Panayiotis E. Stevis
article en

Abstract

Inflammatory hepatocellular adenomas (IHCAs) are benign liver tumors primarily driven by somatic mutations in the gp130 receptor, resulting in its constitutive activation. To uncover the structural mechanisms underlying this activation, we employ cryo-electron microscopy and mutagenesis to study five representative IHCAs-associated gp130 mutants and two engineered mutants with ligand-independent activity. Most mutants form “X”-shaped dimers through a 3D domain-swapping mechanism, characterized by large separations between juxtamembrane domains and reliant on D1 domain-mediated “tip-to-tip” interactions for dimer clustering and activation. A rare mutant displays a distinct “Y”-shaped dimer conformation, with closely aligned juxtamembrane domains enabling direct activation independent of dimer clustering. These findings highlight the diversity of gp130 mutant activation mechanisms and provide a foundation for developing therapeutic strategies targeting aberrant gp130 signaling in IHCAs.

Nature Communications
Regeneron (United States) (US)
Good health and well-being
Cytokine Signaling Pathways and Interactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon